Theriva Biologics, Inc. (TOVX)
NYSE: TOVX · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 1996
Who runs Theriva Biologics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Shallcross Steven A
CEO and CFO. First filing Jun 2015, latest Jan 6, 2026, 9 filings in all.
Officers reporting now
1
of 4 people with a filing in the last fifteen months
Directors reporting now
3
8 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Shallcross Steven A | CEO and CFO | Jun 2015 | Jan 6, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kraws Jeffrey J | director | Nov 2006 | Jan 6, 2026 | none |
| Monahan John J | director | Nov 2020 | Jan 6, 2026 | none |
| Wolf Jeffrey Alan | director | Nov 2006 | Jan 6, 2026 | none |
Earlier names on the record6, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.